Neus ยท Neutral News Analysis
US Health Secretary RFK Jr. Moves to Expand Access to Unapproved Peptides Despite FDA Warnings
The Trump administration is easing access to popular peptide compounds, including GLP-1 drugs, allowing for widespread use despite opposition from FDA scientists. Health experts have cautioned against using these unproven drugs, citing a lack of clinical trials and unknown long-term effects on humans.
Referenced News Coverage (3 sources)
- RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them (The Independent UK)
- FDA scientists opposed the Trump administration's effort to ease peptides access (The Independent UK)
- US Health Secretary RFK Jr to expand access to unapproved peptides (BBC News)